Cheol‐In Kang

12.3k total citations · 1 hit paper
283 papers, 8.1k citations indexed

About

Cheol‐In Kang is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Cheol‐In Kang has authored 283 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Epidemiology, 122 papers in Infectious Diseases and 92 papers in Molecular Medicine. Recurrent topics in Cheol‐In Kang's work include Antibiotic Resistance in Bacteria (92 papers), Bacterial Identification and Susceptibility Testing (69 papers) and Antimicrobial Resistance in Staphylococcus (62 papers). Cheol‐In Kang is often cited by papers focused on Antibiotic Resistance in Bacteria (92 papers), Bacterial Identification and Susceptibility Testing (69 papers) and Antimicrobial Resistance in Staphylococcus (62 papers). Cheol‐In Kang collaborates with scholars based in South Korea, United States and Taiwan. Cheol‐In Kang's co-authors include Kyong Ran Peck, Doo Ryeon Chung, Myoung‐don Oh, Kang Won Choe, Hong Bin Kim, Jae‐Hoon Song, Sung‐Han Kim, Kwan Soo Ko, Nam Yong Lee and Wan Beom Park and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Cheol‐In Kang

275 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome

2005 543 citations Cheol‐In Kang, Sung‐Han Kim et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheol‐In Kang South Korea	43	3.2k	3.2k	2.3k	1.7k	1.4k	283	8.1k
Kyong Ran Peck South Korea	51	3.7k 1.2×	3.2k 1.0×	3.6k 1.6×	1.5k 0.9×	1.1k 0.8×	443	10.0k
Mario Tumbarello Italy	52	3.5k 1.1×	3.8k 1.2×	2.8k 1.2×	1.8k 1.0×	1.7k 1.2×	155	8.4k
Doo Ryeon Chung South Korea	45	2.9k 0.9×	2.5k 0.8×	2.8k 1.2×	1.3k 0.8×	911 0.6×	299	8.0k
Teresa Spanu Italy	43	2.3k 0.7×	3.5k 1.1×	1.4k 0.6×	1.8k 1.1×	1.4k 1.0×	130	6.5k
Mitchell J. Schwaber Israel	40	2.1k 0.6×	4.6k 1.5×	2.4k 1.0×	2.2k 1.3×	1.9k 1.4×	108	7.4k
Alexander J. Kallen United States	36	1.8k 0.6×	2.5k 0.8×	1.9k 0.8×	1.2k 0.7×	1.1k 0.8×	101	6.3k
Mario Venditti Italy	54	4.3k 1.3×	2.2k 0.7×	3.8k 1.7×	1.4k 0.8×	989 0.7×	281	9.7k
Winfried V. Kern Germany	55	3.1k 0.9×	2.6k 0.8×	3.0k 1.3×	2.0k 1.2×	918 0.6×	289	10.1k
Dawn Sievert United States	14	2.4k 0.7×	2.2k 0.7×	3.5k 1.5×	1.9k 1.1×	1.2k 0.8×	27	7.9k
Jan Kluytmans Netherlands	42	2.1k 0.6×	2.4k 0.8×	3.1k 1.4×	1.5k 0.9×	956 0.7×	199	8.5k

Countries citing papers authored by Cheol‐In Kang

Since Specialization

Citations

This map shows the geographic impact of Cheol‐In Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol‐In Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol‐In Kang more than expected).

Fields of papers citing papers by Cheol‐In Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheol‐In Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol‐In Kang. The network helps show where Cheol‐In Kang may publish in the future.

Co-authorship network of co-authors of Cheol‐In Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheol‐In Kang. A scholar is included among the top collaborators of Cheol‐In Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheol‐In Kang. Cheol‐In Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bae, Youngoh, et al.. (2025). Risk of mood disorders after epilepsy diagnosis: A nationwide retrospective cohort study in South Korea. The International Journal of Psychiatry in Medicine. 60(6). 662–680.

Koh, June‐Young, Jae‐Hoon Ko, So Yun Lim, et al.. (2023). Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19. Clinical Immunology. 251. 109628–109628. 1 indexed citations

Choi, Jong Rim, Kyungmin Huh, Doo Ryeon Chung, et al.. (2023). Trend of immunity against measles and varicella zoster virus in healthcare workers in Korea. Vaccine. 41(32). 4679–4684. 4 indexed citations

Baek, Jin Yang, Jae‐Hoon Ko, Sun Young Cho, et al.. (2023). Extensively drug-resistant Enterobacter ludwigii co-harbouring MCR-9 and a multicopy of blaIMP-1 in South Korea. Journal of Global Antimicrobial Resistance. 36. 217–222. 3 indexed citations

Baek, Jin Yang, Juyoun Shin, Yeun‐Jun Chung, et al.. (2021). Genome-Wide Analysis of the Temporal Genetic Changes in Streptococcus pneumoniae Isolates of Genotype ST320 and Serotype 19A from South Korea. Microorganisms. 9(4). 795–795.

Nham, Eliel, Kyungmin Huh, Sun Young Cho, et al.. (2020). Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producingKlebsiella pneumoniaeBacteremia in Cancer Patients. Infection and Chemotherapy. 52(1). 59–59. 11 indexed citations

Kang, Cheol‐In, Jieun Kim, Dae Won Park, et al.. (2018). Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections. Infection and Chemotherapy. 50(1). 67–67. 139 indexed citations

Seok, Hyeri, Cheol‐In Kang, Kyungmin Huh, et al.. (2018). Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae. Microbial Drug Resistance. 24(9). 1412–1416. 6 indexed citations

Lee, Mi Suk, Jee Youn Oh, Cheol‐In Kang, et al.. (2018). Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia. Infection and Chemotherapy. 50(2). 160–160. 42 indexed citations

10.

Huh, Kyungmin, Doo Ryeon Chung, Kim Ys, et al.. (2018). Factors affecting the public awareness and behavior on antibiotic use. European Journal of Clinical Microbiology & Infectious Diseases. 37(8). 1547–1552. 15 indexed citations

11.

Cho, Sun Young, Cheol‐In Kang, Min Kyeong, et al.. (2015). Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131. Microbial Drug Resistance. 21(4). 463–469. 18 indexed citations

12.

Cheong, Hae Suk, Kwan Soo Ko, Cheol‐In Kang, et al.. (2012). Clinical Significance of Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Blood Isolates with Inducible AmpC β-Lactamase. Microbial Drug Resistance. 18(4). 446–452. 10 indexed citations

13.

Moon, Soo‐youn, Kyong Ran Peck, Hyun‐Ha Chang, et al.. (2012). Clinical Experience of Tigecycline Treatment in Infections Caused by Extensively Drug-Resistant Acinetobacter spp.. Microbial Drug Resistance. 18(6). 562–566. 17 indexed citations

14.

Park, So Yeon, Cheol‐In Kang, Eun‐Jeong Joo, et al.. (2012). Risk Factors for Multidrug Resistance in Nosocomial Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae. Microbial Drug Resistance. 18(5). 518–524. 20 indexed citations

15.

Lee, Jeong-A, Cheol‐In Kang, Eun‐Jeong Joo, et al.. (2011). Epidemiology and Clinical Features of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Klebsiella pneumoniae. Microbial Drug Resistance. 17(2). 267–273. 39 indexed citations

16.

Joo, Eun‐Jeong, Cheol‐In Kang, Young Eun Ha, et al.. (2011). Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on Outcome. Microbial Drug Resistance. 17(2). 305–312. 56 indexed citations

17.

Kang, Cheol‐In, Sung‐Han Kim, Wan Beom Park, et al.. (2005). Risk Factors for Antimicrobial Resistance and Influence of Resistance on Mortality in Patients with Bloodstream Infection Caused by Pseudomonas aeruginosa. Microbial Drug Resistance. 11(1). 68–74. 81 indexed citations

18.

Kang, Cheol‐In, Hong Bin Kim, Myoung‐don Oh, Eui-Chong Kim, & Kang Won Choe. (2004). Risk Factors for Ciprofloxacin Resistance in Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae. Microbial Drug Resistance. 10(1). 71–76. 16 indexed citations

19.

Kim, Hong Bin, Hee‐Chang Jang, Sung‐Han Kim, et al.. (2004). A High Frequency of Macrolide-Lincosamide-Streptogramin Resistance Determinants in Staphylococcus aureus Isolated in South Korea. Microbial Drug Resistance. 10(3). 248–254. 19 indexed citations

20.

Pai, Hyunjoo, Cheol‐In Kang, Wan Beom Park, et al.. (2004). Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 48(10). 3720–3728. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact